340binformed.org

Your Free Source for 340B News and Commentary

  • About us
  • Advertise
  • Contact
  • 340B Health

Eli Lilly Again Reports Big Revenue Gains From 340B Denials

 

Nov. 1, 2021– The first drug company to deny 340B drug pricing program discounts to safety-net hospitals, health centers, and clinics saw its U.S. revenues jump 26% in the third quarter of 2021, thanks in part to the higher prices it is charging for diabetes drugs sold to 340B providers. In a public financial report, Eli Lilly said its third-quarter U.S. revenue totaled … [Read more...]

Faces of 340B: Community Pharmacy Partnerships Benefit Patients with Diabetes

 

Oct. 28, 2021 – Courtney Riddle’s patient was at a family-owned pharmacy in Magnolia, Ark., where she always picked up her medications, including the diabetes drug Jardiance that was helping to control her blood sugar levels. The patient’s out-of-pocket cost typically was $16.43 for a month’s supply, but this time it was much different. The patient received a note that said … [Read more...]

340B Is a Key Element of the Mission Against Breast Cancer

 

Oct. 22, 2021– Each October, national organizations aim to make more Americans aware of what they can do to prevent and treat breast cancer as well as support people whose lives have been affected by the disease. Breast Cancer Awareness Month also is a time to look at how the 340B drug pricing program can help expand prevention and treatment efforts. Screenings Are … [Read more...]

Federal Report Suggests Another Reason To End 340B Orphan Drug Loophole

 

Oct. 18, 2021– A new federal government report could add momentum to efforts on Capitol Hill to end limitations on 340B price discounts for orphan drugs purchased by certain safety-net hospitals. The report suggests that drug companies might be seeking orphan status for their products to maximize revenues and avoid paying 340B discounts on drugs widely used to treat common … [Read more...]

Seventh Drug Company Told It is Violating 340B Law

 

Oct. 12, 2021– Eight drug companies have restricted access to discounts to safety-net providers through the 340B drug pricing program on drugs dispensed at community-based pharmacies. Now the government officially has informed all but one of those companies that they are in violation of federal law and must restore the discounted pricing. The most recent recipient of a … [Read more...]

HHS Takes Vital Next Step Toward Ending 340B Pricing Denials

 

Oct. 1, 2021– The federal government has taken dramatic action to get drug companies to restore 340B pricing for outpatient prescription drugs dispensed by community pharmacies to patients of 340B hospitals. On Sept. 22, the Health Resources & Services Administration (HRSA) sent letters to six drugmakers informing them that the agency is asking the Office of Inspector … [Read more...]

Diabetes Care Bears the Brunt of Drugmakers’ 340B Restrictions

 

Sept. 23, 2021– The eight pharmaceutical companies that are restricting the discounts they offer through the 340B drug pricing program are blocking safety-net hospitals’ access to savings on a wide range of prescription drugs. But perhaps in no area is this more evident than when looking at the prices of diabetes drugs and the levels of lost 340B resources that otherwise would … [Read more...]

« Previous Page
Next Page »

LATEST ARTICLES DELIVERED

Get new article alerts via email.

This field is required.

Check your inbox or spam folder now to confirm your subscription.

FOLLOW | SHARE | LIKE

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

340B Health Twitter

Twitter feed is not available at the moment.

RSS feed: 340B Employed 340B Employed

  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Compliance Analyst Certified | UNC Health November 17, 2026
  • 340B Program Specialist | Vail Health November 17, 2026
  • Pharmacy Manager, 340B Program | Tufts Medical Center November 11, 2026
  • 340B Program Pharmacy Manager | Allies for Health + Wellbeing November 10, 2026

Copyright © 2026 · 340B Health